Genesis Healthcare (NYSE:GEN) is scheduled to be announcing its earnings results after the market closes on Tuesday, February 20th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter.
Shares of Genesis Healthcare (NYSE GEN) opened at $1.02 on Tuesday. The company has a quick ratio of 0.18, a current ratio of 0.18 and a debt-to-equity ratio of -0.22. Genesis Healthcare has a fifty-two week low of $0.60 and a fifty-two week high of $4.05. The firm has a market capitalization of $159.53, a P/E ratio of -0.21 and a beta of 1.58.
A hedge fund recently raised its stake in Genesis Healthcare stock. State Street Corp boosted its position in shares of Genesis Healthcare Inc (NYSE:GEN) by 3.6% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 778,728 shares of the company’s stock after purchasing an additional 26,825 shares during the quarter. State Street Corp owned about 0.95% of Genesis Healthcare worth $1,355,000 as of its most recent filing with the Securities & Exchange Commission. 18.48% of the stock is owned by institutional investors and hedge funds.
About Genesis Healthcare
Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.
Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.